Arrowhead Pharmaceuticals Inc. monthly returns
Arrowhead Pharmaceuticals Inc. has averaged 4.81% a month with dividends reinvested, and risen in 43% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | -28.2% | |
| Oct 2026 | -8.5% | |
| Sep 2026 | -20.6% | |
| Aug 2026 | -2.7% | |
| Jul 2026 | +3.9% | |
| Jun 2026 | +4.6% | |
| May 2026 | +6.0% | |
| Apr 2026 | +17.2% | |
| Mar 2026 | -0.9% | |
| Feb 2026 | -8.7% | |
| Jan 2026 | +4.4% | |
| Dec 2025 | +26.0% | |
| Nov 2025 | +24.3% | |
| Oct 2025 | +22.9% | |
| Sep 2025 | +56.6% | |
| Aug 2025 | +39.4% | |
| Jul 2025 | +0.0% | |
| Jun 2025 | -1.7% | |
| May 2025 | +15.7% | |
| Apr 2025 | +9.0% | |
| Mar 2025 | -32.6% | |
| Feb 2025 | -4.9% | |
| Jan 2025 | +5.7% | |
| Dec 2024 | -27.8% | |
| Nov 2024 | +35.4% | |
| Oct 2024 | -0.7% | |
| Sep 2024 | -18.7% | |
| Aug 2024 | -16.6% | |
| Jul 2024 | +9.9% | |
| Jun 2024 | +13.2% | |
| May 2024 | +1.5% | |
| Apr 2024 | -20.9% | |
| Mar 2024 | -10.9% | |
| Feb 2024 | +0.0% | |
| Jan 2024 | +4.9% | |
| Dec 2023 | +44.3% | |
| Nov 2023 | -13.8% | |
| Oct 2023 | -8.5% | |
| Sep 2023 | -2.8% | |
| Aug 2023 | -19.9% | |
| Jul 2023 | -3.2% | |
| Jun 2023 | +3.6% | |
| May 2023 | -2.8% | |
| Apr 2023 | +39.4% | |
| Mar 2023 | -21.4% | |
| Feb 2023 | -7.7% | |
| Jan 2023 | -13.7% | |
| Dec 2022 | +26.0% | |
| Nov 2022 | -7.5% | |
| Oct 2022 | +5.3% | |
| Sep 2022 | -16.8% | |
| Aug 2022 | -6.6% | |
| Jul 2022 | +20.8% | |
| Jun 2022 | +5.5% | |
| May 2022 | -18.9% | |
| Apr 2022 | -10.6% | |
| Mar 2022 | +4.5% | |
| Feb 2022 | -16.6% | |
| Jan 2022 | -20.4% | |
| Dec 2021 | -5.4% | |
| Nov 2021 | +9.8% | |
| Oct 2021 | +2.2% | |
| Sep 2021 | -7.0% | |
| Aug 2021 | -3.1% | |
| Jul 2021 | -16.3% | |
| Jun 2021 | +14.1% | |
| May 2021 | -0.2% | |
| Apr 2021 | +9.7% | |
| Mar 2021 | -16.8% | |
| Feb 2021 | +3.2% | |
| Jan 2021 | +0.6% | |
| Dec 2020 | +22.7% | |
| Nov 2020 | +9.1% | |
| Oct 2020 | +33.1% | |
| Sep 2020 | +1.9% | |
| Aug 2020 | -1.9% | |
| Jul 2020 | -0.3% | |
| Jun 2020 | +34.0% | |
| May 2020 | -6.4% | |
| Apr 2020 | +19.7% | |
| Mar 2020 | -18.6% | |
| Feb 2020 | -15.6% | |
| Jan 2020 | -33.9% | |
| Dec 2019 | -13.1% | |
| Nov 2019 | +82.3% | |
| Oct 2019 | +42.1% | |
| Sep 2019 | -17.5% | |
| Aug 2019 | +17.6% | |
| Jul 2019 | +9.7% | |
| Jun 2019 | +11.8% | |
| May 2019 | +31.9% | |
| Apr 2019 | -2.0% | |
| Mar 2019 | -6.0% | |
| Feb 2019 | +38.2% | |
| Jan 2019 | +13.7% | |
| Dec 2018 | -14.5% | |
| Nov 2018 | +14.2% | |
| Oct 2018 | -33.6% | |
| Sep 2018 | +29.9% | |
| Aug 2018 | +1.3% | |
| Jul 2018 | +7.1% | |
| Jun 2018 | +26.9% | |
| May 2018 | +67.0% | |
| Apr 2018 | -11.0% | |
| Mar 2018 | +11.3% | |
| Feb 2018 | +4.9% | |
| Jan 2018 | +67.9% | |
| Dec 2017 | +3.1% | |
| Nov 2017 | -1.9% | |
| Oct 2017 | -15.9% | |
| Sep 2017 | +54.6% | |
| Aug 2017 | +59.1% | |
| Jul 2017 | +8.6% | |
| Jun 2017 | +12.5% | |
| May 2017 | -7.1% | |
| Apr 2017 | -16.2% | |
| Mar 2017 | -18.1% | |
| Feb 2017 | +16.5% | |
| Jan 2017 | +25.2% | |
| Dec 2016 | +7.6% |
Monthly total return (since Dec 2021)#
Arrowhead Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 1994, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: -28.23% — 29th of 33 Novembers since 1994 at the last close; the average November returned +5.0%.
| Month | −440%0+440% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +30.2% | +0.6% | 52% | +438.5% 2004 | -43.4% 2016 | |
| Feb | -6.2% | -4.9% | 36% | +38.2% 2019 | -55.2% 2009 | |
| Mar | +9.6% | +0.0% | 48% | +115.1% 2010 | -36.4% 1994 | |
| Apr | +6.6% | +0.0% | 42% | +133.3% 2002 | -37.4% 1996 | |
| May | +1.4% | +0.0% | 36% | +67.0% 2018 | -71.4% 2002 | |
| Jun | +0.1% | +0.0% | 48% | +34.0% 2020 | -33.8% 2007 | |
| Jul | +1.6% | +3.9% | 52% | +88.5% 2013 | -45.5% 1994 | |
| Aug | +4.0% | -2.7% | 36% | +166.0% 1995 | -66.7% 1994 | |
| Sep | +7.1% | +0.0% | 48% | +150.0% 1994 | -83.3% 2002 | |
| Oct | -7.1% | -5.9% | 33% | +42.1% 2019 | -55.9% 2014 | |
| Nov | +5.0% | +0.0% | 47% | +100.0% 1995 | -75.2% 2016 | |
| Dec | +6.5% | -1.3% | 41% | +185.7% 2003 | -86.0% 1994 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from ARWR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Arrowhead Pharmaceuticals Inc.'s average monthly return?
- Arrowhead Pharmaceuticals Inc. has averaged about 4.81% per month (dividends reinvested), positive in roughly 43% of months. The best month was Jan 2004 (+438.5%) and the worst was Dec 1994 (-86.0%).
